On March 6, 2024, Caligan Partners LP announced that it has submitted to Anika Therapeutics, Inc. a notice of its intention to nominate 2 individuals Messrs. Johnson and Jellison for election to the Board in connection with the Company?s 2024 annual meeting of stockholders.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.7 USD | +1.74% | -7.07% | +13.15% |
05-08 | Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09 | MT |
05-08 | Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $40.5M, vs. Street Est of $39.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.15% | 370M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.17% | 32.43B | |
+55.58% | 24.28B | |
-15.07% | 15.52B | |
-41.29% | 12.17B | |
-15.11% | 12.01B | |
-11.75% | 12B | |
+7.49% | 8.87B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Caligan Partners LP Issues Notice of Nominations to Anika Therapeutics, Inc